Edwards Lifesciences
496 hedge funds and large institutions have $12.4B invested in Edwards Lifesciences in 2014 Q3 according to their latest regulatory filings, with 94 funds opening new positions, 157 increasing their positions, 163 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more funds holding
Funds holding: 428 → 496 (+68)
4% less repeat investments, than reductions
Existing positions increased: 157 | Existing positions reduced: 163
12.58% less ownership
Funds ownership: 536.01% → 523.44% (-13%)
Holders
496
Holding in Top 10
10
Calls
$44.2M
Puts
$34.7M
Top Buyers
| 1 | +$132M | |
| 2 | +$98.4M | |
| 3 | +$71.8M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$63.5M |
| 5 |
JP Morgan Chase
New York
|
+$54.4M |
Top Sellers
| 1 | -$628M | |
| 2 | -$181M | |
| 3 | -$128M | |
| 4 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$93.8M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$75.2M |